Mitral valve replacement for Libman–Sacks endocarditis in a patient with antiphospholipid syndrome secondary to systemic lupus erythematosus. Issue 4 (3rd April 2018)

• Record Type: Journal Article
• Authors: Nakasu, Akio; Ishimine, Tohru; Yasumoto, Hiroshi; Tengan, Toshiho; Mototake, Hidemitsu
• Is Part Of: Journal of surgical case reports. Issue 4(2018)
• Publication Date: 2018-04-03
• Subjects: Surgery -- Periodicals; Surgery -- Case studies -- Periodicals; 617.005
• DOI: 10.1093/jscr/rjy069
• Languages: English
• ISSNs: 2042-8812

Abstract

Abstract: Libman–Sacks endocarditis is a relatively rare sterile verrucous vegetative lesion observed in systemic lupus erythematosus (SLE)/antiphospholipid syndrome (APLS) patients. Most patients with this condition are asymptomatic. Here we report a case of a 46-year-old woman with APLS secondary to SLE complicated with frequent thromboembolic events due to a mitral valve mass. We performed minimally invasive mitral valve replacement with a mechanical prosthetic valve, and she was successfully discharged 14 days after surgery. Thus, Libman–Sacks endocarditis may be an indication for mitral valve replacement.